hotspot -WSS

hotspot

author：Wikipedia 2025-09-30 17:05:16 - browse：98

Verve Therapeutics said Sunday that the first 10 people to receive a one-time treatment powered by a form of CRISPR called base editing showed reductions in bad cholesterol levels — study results that are preliminary but signal the potential for gene-editing treatments to benefit people with an inherited type of cardiovascular disease.

Three of the study participants treated with potentially therapeutic doses of the Verve drug, called VERVE-101, showed reductions in LDL-C levels of 39%, 48%, and 55%, respectively. The latter patient’s decline in so-called “bad” cholesterol was maintained for six months.

The Verve-101 study results were presented at the American Heart Association conference and are the first data in patients from a therapy that uses base editing to change individual letters of DNA. Verve licensed the base-editing technology from Beam Therapeutics.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Bernie brings in new pharma CEOs to talk drug prices

WSS

Primary care doctor shortage won't be solved by free med school tuition

A protest over insulin prices is seen as a fight for life

Crowdfunding for medical bills sidesteps core problem, author says

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Cano Health’s bankruptcy is a warning for Medicare Advantage

entertainment

hotspot

hotspot

Guidelines to prevent youth baseball injuries need more muscle

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

New air purifier tech could be key to improving indoor air quality

The effects of a landmark ruling on DNA ownership are becoming clearer

Heart attack and stroke risk calculators need revising

Cano Health’s bankruptcy is a warning for Medicare Advantage

Sports medicine is finally prioritizing gender equality

Cano Health’s bankruptcy is a warning for Medicare Advantage

Medical leaders decry Supreme Court decision on affirmative action

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

explore

The CDC's new social media misinformation war

Welsh Carson private equity firm escapes from FTC antitrust case

Readout LOUD: Venture capital, Gilead, and more M&A

Black vets could get higher VA benefits if race not used in lung test

Warren pushes Witty on UnitedHealth's control over physicians

A single Democrat is willing to weaken Medicare negotiation power

hotspot

focus

Wikipedia

hotspot